OPKO Health Stock
OPKO Health, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Phillip Frost
- Employees
- 2,275
- Market cap
- $1.1 B
- IPO
- 02/11/1995
- Web
- www.opko.com
OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a…
OPKO Health stock: price history
1D
-5.0%
1W
+10.9%
1M
-5.0%
6M
+23.4%
YTD
+21.4%
1Y
+2.0%
2Y
+2.7%
5Y
-58.9%
10Y
-83.7%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~24% stronger price swings than usual
Ask the agents about OPKO Health
Analyst assessment of OPKO Health
PRICE TARGET LOW
US$2.25
CONSENSUS
US$3.13
MEDIAN
US$3.13
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
9
BUY
3
HOLD
1
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 16/10/2026
OPKO Health stock metrics
P/E
-16.05
P/B
0.98
EV/EBITDA
24.71
RETURN ON EQUITY
-0.7%
NET MARGIN
-5.1%
DEBT/EQUITY
0.33
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
43.4%
FLOAT SHARES
323,727,331
AVG. DAILY VOLUME (30D)
4,277,675
Insider transactions (SEC)
Rubin Steven D
Logal Adam
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.0%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about OPKO Health stock
What does OPKO Health do?
OPKO Health, Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Phillip Frost, the company employs around 2,275 people.
The IPO was on 02/11/1995; the stock trades on NASDAQ under the ticker OPK.
What do analysts say about OPKO Health stock?
13 analysts rate the stock, the consensus is Buy (as of 16/10/2026).
The average price target is US$3.13, ranging from US$2.25 to US$4.00, with a median of US$3.13.
This is an external assessment, not a statement by Market Jury.
When does OPKO Health report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 24% stronger than usual.
Does OPKO Health pay a dividend?
No, OPKO Health currently does not pay a dividend.
Which stocks are comparable to OPKO Health?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get OPKO Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess OPKO Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.